Smiling senior woman in white shirt indoors

Home / News / FDA

FDA · September 25, 2026

FDA clears REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5) (Hyundai Bioland Co., Ltd.)

The FDA cleared REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5), a animal-source bone grafting material from Hyundai Bioland Co., Ltd. (Cheongju-Si, KR), under 510(k) K254210 on September 25, 2026.

Source
U.S. FDA 510(k) database
accessdata.fda.gov
Published
September 25, 2026
Type
FDA
Checked
October 16, 2026

Read the source

Featured

Featured doctor

Featured doctors advertise with the publisher. Featured placement does not change a score or a rank. Disclosure

Dr. Michael Pawlus
Featured

ICOI Fellow, ICOI Diplomate · AAP member

Featured doctorDr. Michael Pawlus · Sarasota